HepaTx Corporation,Namocell Inc., and Takara Bio USA, and Inc. (TBUSA) announced successful completion of the moment phase of their collaboration on single cell analysis of hepatocyte-like cells (iHeps) differentiated from adipose tissue-derived stromal cells (ASCs) using Namocell’s Single Cell Dispensers and Takara Bio’s SMART-seq® kits to characterize HepaTx’s novel cell therapies for liver disease.
Source: the-scientist.com